- President and Chief Executive Officer, Interventional Therapeutic Solutions Inc
- Member of the Board of Directors, NEUROMetrix
- Member of the Harvard-MIT Health Sciences and Technology Advisory Council
- Member of the Board of Visitors, Whitaker College of Health Sciences and Technology, M.I.T.

Career Highlights:
Dr. Goodman received a BAS in applied science and bioengineering and a MSE in bioengineering from the University of Pennsylvania. He also received an MD, cum laude, from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology.

Since 2004, Dr. Goodman has served as president and chief executive officer of Interventional Therapeutic Solutions Inc; an implantable drug delivery systems company. He also currently serves on the board of directors of NEUROMetrix, a neurodiagnostics company founded and run by classmate and fellow HST alumnus Shai Gozani, MD 1994, PhD.

Dr. Goodman has been an independent consultant providing product design, regulatory and analytical consulting services to corporations within the medical device, biopharmaceutical, and health and services markets from 2003 to 2004, as well as from 2001 to 2002. From 2002 to 2003, Dr. Goodman served as chairman, president and chief executive officer of Pherin Pharmaceuticals, a pharmaceutical discovery and development company. From 1994 to 2001, he held various positions, including chief executive officer, chief medical officer and director, for LifeMasters Supported SelfCare, Inc., a disease management services company that he founded. In 1990, while still a first year HST student, David co-founded Aradigm (Nasdaq: ARDM), which focused on developing novel devices and formulations for pulmonary drug delivery. Aradigm went public in 1996. David began his career at Nellcor (TYCO Healthcare) in 1982, as one of the original designers of the Nellcor pulse oximeter.

Dr. Goodman holds 18 U.S. patents and is licensed to practice medicine in California.